Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001

NCT05508594 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: CT001
DRUG: Placebo
DRUG: Sufentanil
DRUG: Ketamine

Sponsor

Cessatech A/S